Primaquine for plasmodium vivax malaria treatment – authors' reply
Main Authors: | Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2020
|
Registos relacionados
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Por: Setyadi, A, et al.
Publicado em: (2019) -
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
Por: Watson, JA, et al.
Publicado em: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Por: Taylor, WRJ, et al.
Publicado em: (2023) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
Por: Thriemer, K, et al.
Publicado em: (2020) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
Por: Luzzi, G, et al.
Publicado em: (1992)